Elevated levels of soluble Fas in systemic lupus erythematosus: Comment on the article by Knipping et al
Open Access
- 1 September 1996
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (9) , 1612-1614
- https://doi.org/10.1002/art.1780390926
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Levels of soluble fas/APO‐1 /CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritisArthritis & Rheumatism, 1995
- Lack of correlation between serum soluble fas/APO‐1 levels and autoimmune diseaseArthritis & Rheumatism, 1995
- Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteasesEuropean Journal of Immunology, 1995
- Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.The Journal of Immunology, 1995
- Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemiasBlood, 1995
- Expression of the functional soluble form of human fas ligand in activated lymphocytes.The EMBO Journal, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994